# Hydralazine

## Apresoline 50mg

| TAH Drug Code      | [**OAPR5**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OAPR5)                                                                                                                                                                    |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Hypertension.                                                                                                                                                                                                                                 |
| Dosing             | HTN Adult: 10-50 mg QID slowly titrate up (Maximum dose 300 mg/day). Child: 0.75 mg/kg/day in 4 divided doses, up to 7.5 mg/kg/day. (Maximum dose 300mg/day).                                                                                 |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                 |
| Contraindications  | Idiopathic SLE and related diseases. Severe tachycardia and heart failure with high cardiac output. Myocardial insufficiency due to mechanical obstruction. Right ventricular heart failure due to pulmonary HTN. Dissecting aortic aneurysm. |
| Adverse Effects    | Tachycardia, palpitation, anginal symptoms, flushing, headache, dizziness, nasal congestion, GI disturbances.                                                                                                                                 |
| Pregnancy          | Human Data Suggest Risk in 3rd Trimester                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                 |

